These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2006-001469-41 Randomized, open label, multicenter ABPM study to evaluate the effects of barnidipine as add-on therapy in patients with hypertension not adequately controlled on therapy with losartan bad-data
Completed, but no date Terminated 2007-000947-88 Therapeutic Strategies of Prevention of Diabetes and Hypertension in Subjects with Metabolic Syndrome and High-Normal Blood Pressure. bad-data
Ongoing 2008-000540-14 Role of the renin-angiotensin system in the cardiovascular, metabolic, neurologic and respiratory response to hypobaric hypoxia during sustained exposure to high altitude. not-yet-due
Ongoing 2008-006379-65 Evaluation of the benefit-risk profile of retinoic acid in the treatment of Cushing`s disease not-yet-due
Ongoing 2010-019986-27 Breathing disorders in heart failure: high altitude hypoxia as a model to define diagnostic tools, therapeutic strategies and gender related differences. not-yet-due
Listed as ongoing, but also has a completion date 2012-001757-21 European Society of Hypertension and Chinese Hypertension League Stroke in Hypertension Optimal Treatment Trial 2020-12-31 bad-data
Ongoing 2012-005830-12 Parenteral iron supplementation, chemoreflex response, quality of life and exercise capacity in patients with chronic heart failure Terapia marziale endovenosa, risposte chemoriflesse, qualita' di ... not-yet-due
Ongoing 2014-003459-76 REducing blood pressure Variability in Essential hypertension with RAmipril vErsus Nifedipine GITS Trial Riduzione della variabilità della pressione arteriosa nell’ipertensione essenziale con ramip... not-yet-due
Completed, but no date, and reported results Terminated 2019-004917-15 Crossover, Double-blind, Phase 2 Study of a Fixed Dose Combination of Reboxetine\Oxybutynin (AD128) Versus Placebo in Obstructive Sleep Apnea (RebOx) Studio di Fase 2, in doppio cieco, cross-over, ... bad-data
Ongoing, reported early 2020-000250-94 Mutation-specific therapy for the long QT syndrome Terapia mutazione-specifica per la sindrome del QT lungo not-yet-due
Ongoing 2022-000693-26 Crossover, Double-blind, Phase 2 Study of a Fixed Dose Combination of Atomoxetine and Acetazolamide Versus Placebo in Obesity Hypoventilation Syndrome Crossover, doppio cieco, studio di fase 2 di u... not-yet-due